A citation-based method for searching scientific literature

Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu, Da-Yan Wang, Yue-Long Shu, Ling-Pei Ho, Paul Kellam, Andrew McMichael, Tao Dong. Nat Commun 2013
Times Cited: 163







List of co-cited articles
722 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
459
87

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
808
58

Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.
Zhongfang Wang, Anli Zhang, Yanmin Wan, Xinian Liu, Chao Qiu, Xiuhong Xi, Yanqin Ren, Jing Wang, Yuan Dong, Meijuan Bao,[...]. Proc Natl Acad Sci U S A 2014
180
40

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
148
38

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
240
37

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
E Kaitlynn Allen, Adrienne G Randolph, Tushar Bhangale, Pranay Dogra, Maikke Ohlson, Christine M Oshansky, Anthony E Zamora, John P Shannon, David Finkelstein, Amy Dressen,[...]. Nat Med 2017
82
42

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
348
31

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
198
31

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
197
31

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
163
30

IFITM3 and susceptibility to respiratory viral infections in the community.
Tara C Mills, Anna Rautanen, Katherine S Elliott, Tom Parks, Vivek Naranbhai, Margareta M Ieven, Christopher C Butler, Paul Little, Theo Verheij, Chris S Garrard,[...]. J Infect Dis 2014
54
48

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
104
22

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
114
22

Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Adrienne G Randolph, Wai-Ki Yip, Emma Kaitlynn Allen, Carrie M Rosenberger, Anna A Agan, Stephanie A Ash, Yu Zhang, Tushar R Bhangale, David Finkelstein, Natalie Z Cvijanovich,[...]. J Infect Dis 2017
34
64

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
55
38

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
257
20

Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
76
26

IFITM3 and severe influenza virus infection. No evidence of genetic association.
M López-Rodríguez, E Herrera-Ramos, J Solé-Violán, J J Ruíz-Hernández, L Borderías, J P Horcajada, E Lerma-Chippirraz, O Rajas, M Briones, M C Pérez-González,[...]. Eur J Clin Microbiol Infect Dis 2016
26
76

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
198
19

The broad-spectrum antiviral functions of IFIT and IFITM proteins.
Michael S Diamond, Michael Farzan. Nat Rev Immunol 2013
399
19

Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort.
Yonghong Zhang, Shokouh Makvandi-Nejad, Ling Qin, Yan Zhao, Tong Zhang, Lili Wang, Emmanouela Repapi, Stephen Taylor, Andrew McMichael, Ning Li,[...]. AIDS 2015
31
61


IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Nelson Lee, Bin Cao, Changwen Ke, Hongzhou Lu, Yunwen Hu, Claudia Ha Ting Tam, Ronald Ching Wan Ma, Dawei Guan, Zhaoqin Zhu, Hui Li,[...]. J Infect Dis 2017
28
67

Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Shokouh Makvandi-Nejad, Henry Laurenson-Schafer, LiLi Wang, Dannielle Wellington, Yan Zhao, Boquan Jin, Ling Qin, Kerry Kite, Hooman K Moghadam, Chaojun Song,[...]. J Infect Dis 2018
24
79

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
131
17

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Jessica M Weidner, Dong Jiang, Xiao-Ben Pan, Jinhong Chang, Timothy M Block, Ju-Tao Guo. J Virol 2010
207
17


Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.
Michael J Ciancanelli, Sarah X L Huang, Priya Luthra, Hannah Garner, Yuval Itan, Stefano Volpi, Fabien G Lafaille, Céline Trouillet, Mirco Schmolke, Randy A Albrecht,[...]. Science 2015
217
17

Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Xianxian Yang, Bin Tan, Xipeng Zhou, Jian Xue, Xian Zhang, Peng Wang, Chuang Shao, Yingli Li, Chaorui Li, Huiming Xia,[...]. PLoS One 2015
28
60

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Jacob S Yount, Bruno Moltedo, Yu-Ying Yang, Guillaume Charron, Thomas M Moran, Carolina B López, Howard C Hang. Nat Chem Biol 2010
238
17

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
125
16

IFITM3 polymorphism rs12252-C restricts influenza A viruses.
David Evan Joseph Williams, Wan-Lin Wu, Christopher Robert Grotefend, Vladimir Radic, Changik Chung, Young-Hwa Chung, Michael Farzan, I-Chueh Huang. PLoS One 2014
33
48

IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.
Y Xuan, L N Wang, W Li, H R Zi, Y Guo, W J Yan, X B Chen, P M Wei. Epidemiol Infect 2015
24
66


IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
106
15

IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.
Yang Pan, Peng Yang, Tao Dong, Yi Zhang, Weixian Shi, Xiaomin Peng, Shujuan Cui, Daitao Zhang, Guilan Lu, Yimeng Liu,[...]. Front Cell Infect Microbiol 2017
19
78

IFITM proteins-cellular inhibitors of viral entry.
Se Smith, S Weston, P Kellam, M Marsh. Curr Opin Virol 2014
72
19

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
14

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.
Nicholas M Chesarino, Temet M McMichael, Jacob S Yount. Future Microbiol 2014
41
34

Interferon-induced transmembrane protein 3 is a type II transmembrane protein.
Charles C Bailey, Hema R Kondur, I-Chueh Huang, Michael Farzan. J Biol Chem 2013
60
21

A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection.
Jie Zhou, Kelvin Kai-Wang To, Hui Dong, Zhong-Shan Cheng, Candy Choi-Yi Lau, Vincent K M Poon, Yan-Hui Fan, You-Qiang Song, Herman Tse, Kwok-Hung Chan,[...]. J Infect Dis 2012
56
23

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
78
15

The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Matthew J Gorman, Subhajit Poddar, Michael Farzan, Michael S Diamond. J Virol 2016
54
22

Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.
Vânia Gaio, Baltazar Nunes, Pedro Pechirra, Patrícia Conde, Raquel Guiomar, Carlos Matias Dias, Marta Barreto. PLoS One 2016
12
91


Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
Susana David, Vanessa Correia, Liliana Antunes, Ricardo Faria, José Ferrão, Paula Faustino, Baltazar Nunes, Fernando Maltez, João Lavinha, Helena Rebelo de Andrade. Immunogenetics 2018
13
84


Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis.
Suchitra S Prabhu, Trirupa Tapas Chakraborty, Nirmal Kumar, Indranil Banerjee. Gene 2018
17
64

A membrane topology model for human interferon inducible transmembrane protein 1.
Stuart Weston, Stephanie Czieso, Ian J White, Sarah E Smith, Paul Kellam, Mark Marsh. PLoS One 2014
42
23

Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming.
Giuseppe Infusini, Jeffrey M Smith, He Yuan, Angela Pizzolla, Wy Ching Ng, Sarah L Londrigan, Ashraful Haque, Patrick C Reading, Jose A Villadangos, Linda M Wakim. PLoS One 2015
20
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.